Data Analyst II, Go To Market Strategy at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Bachelor’s or Master’s degree in Statistics, Mathematics, Operations Research, Business Analytics, or a related discipline
3 to 5 years of hands-on experience in GTM analytics, customer targeting, segmentation, sizing, and territory structuring, preferably within the pharmaceutical industry
Strong expertise in commercial analytics, GTM strategy, targeting, segmentation, and market sizing for Pharma or Life Sciences
Advanced proficiency in Excel (including VBA), PowerBI, Tableau, Python, SQL, and other data management and visualization platforms
Experience working with patient and claims data, specifically IQVIA and SHS datasets
Proficiency with CRM tools (e.g., Veeva) and territory alignment platforms
Experience analyzing IQVIA sales, call activity, and Rx datasets
Excellent data storytelling, presentation, and stakeholder management skills
Strong business acumen and ability to translate analytical findings into strategic, actionable recommendations
Experience in digital analytics, process automation, AI/ML, and decision science methodologies
Independent problem-solving and project management skills, with a solution-oriented mindset

Responsibilities

Design, develop, and execute Field force sizing, GTM analytical frameworks for Pharma brands, including customer targeting, segmentation, opportunity sizing, and territory structuring
Advance segmentation and targeting models using real-world data and machine learning techniques to identify high-value customers and growth opportunities
Collaborate cross-functionally with Commercialization (including medical), Commercial & Medical Analytics, Data Strategy and IT teams to align on GTM deliverables and implementation roadmaps
Prepare, visualize, and present GTM recommendations and dashboards for senior leadership and field teams, translating analytics into actionable plans
Innovate and automate GTM processes, deploying digital analytics and AI/ML tools to improve recommendations and reduce time to insights
Manage ongoing stakeholder communications, promoting knowledge sharing, feedback integration, and best practices in GTM analytics
Continuously evaluate industry trends and benchmarks, recommending new approaches to GTM strategy and field effectiveness

Skills

Customer Targeting

Market Segmentation

Territory Structuring

Field Force Sizing

Machine Learning

Real-World Data

Pharmaceutical Datasets

Commercial Analytics

Advanced Analytics Platforms

GTM Planning

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free